BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/29/2021 7:57:41 AM | Browse: 503 | Download: 1066
 |
Received |
|
2020-10-12 12:29 |
|
Peer-Review Started |
|
2020-10-12 12:30 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2020-11-23 06:10 |
|
Revised |
|
2020-12-08 09:35 |
|
Second Decision |
|
2021-01-06 12:26 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2021-01-06 18:32 |
|
Articles in Press |
|
2021-01-06 18:32 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-01-26 11:41 |
|
Publish the Manuscript Online |
|
2021-01-29 07:57 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Case Report |
| Article Title |
Vedolizumab in Crohn’s disease with rectal fistulas and presacral abscess: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Heng Yeh, Chia-Jung Kuo, Ren-Chin Wu, Chien-Ming Chen, Wen-Sy Tsai, Ming-Yao Su, Cheng-Tang Chiu and Puo-Hsien Le |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Puo-Hsien Le, MD, Assistant Professor, Department of Gastroenterology and Hepatology, Chang Gung Memorial Hospital, Linkou Branch, No. 5 Fuxing Street, Guishan District, Taoyuan 333, Taiwan. puohsien@gmail.com |
| Key Words |
Vedolizumab; Crohn's disease; Rectoprostatic fistula; Rectal pre-sacral fistula; Pre-sacral abscess; Case report |
| Core Tip |
Fistulas and intraabdominal fistulas are common complications of Crohn’s disease (CD) and tumor necrosis factor antagonists combined with percutaneous drainage or surgical intervention is the optimal treatment for fistulizing CD with intraabdominal abscess. However, no previous study has reported the efficacy of vedolizumab in this complicated situation. This 47-year-old male presented with CD with complex fistulas and pre-sacral abscess. He received vedolizumab with transverse colostomy and the follow-up sigmoidoscopy 6 mo later showed mucosal healing without any visible fistula tracts. We think early vedolizumab treatment with stool diversion are effective and safe in treating CD with complex fistulas and abscess formation. |
| Publish Date |
2021-01-29 07:57 |
| Citation |
Yeh H, Kuo CJ, Wu RC, Chen CM, Tsai WS, Su MY, Chiu CT, Le PH. Vedolizumab in Crohn’s disease with rectal fistulas and presacral abscess: A case report. World J Gastroenterol 2021; 27(5): 442-448 |
| URL |
https://www.wjgnet.com/1007-9327/full/v27/i5/442.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v27.i5.442 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
